Will estrone-3-glucuronide (E1G) and progesterone (PDG) levels be elevated during the luteal phase in a pregnant female of reproductive age?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

E1G and PDG Elevation in Early Pregnancy During Luteal Phase

Yes, both estrone-3-glucuronide (E1G) and pregnanediol-3-glucuronide (PDG) levels will be elevated and remain elevated during the luteal phase if pregnancy occurs, distinguishing conception cycles from non-conception cycles. 1

Hormonal Patterns in Pregnant vs Non-Pregnant Luteal Phases

E1G (Estrone-3-Glucuronide) Elevation

  • E1G concentrations are significantly higher throughout conception cycles compared to non-conception cycles, with an average difference of 18-20 ng/mg creatinine daily. 1

  • In clinical pregnancy cycles, E1G levels remain elevated during the late luteal phase, whereas they drop in non-conception cycles. 2

  • The late luteal rise in estradiol (measured as E1G in urine) is a more sensitive indicator of pregnancy than progesterone elevation alone. 2

  • Women who achieve clinical pregnancy demonstrate consistently higher E1G levels throughout their cycles compared to their own non-conception cycles. 1

PDG (Pregnanediol-3-Glucuronide) Elevation

  • PDG rises approximately 24-36 hours after ovulation and remains elevated throughout the luteal phase in pregnancy cycles. 3

  • Three consecutive positive PDG tests (≥5 μg/mL threshold) after the LH surge confirm ovulation with high specificity, and these levels remain elevated in conception cycles. 3

  • In fertile cycles that result in pregnancy, late luteal progesterone levels remain higher than midluteal values, whereas they drop in non-fertile cycles. 2

Clinical Significance for Pregnancy Detection

Distinguishing Features

  • Both E1G and PDG measurements in urine are markedly elevated during pregnancy, making them useful for early pregnancy detection. 4

  • E1G measurement is particularly valuable for early pregnancy diagnosis, while sustained elevation of both hormones confirms ongoing pregnancy. 4

  • The progesterone/estradiol ratio remains stable during the luteal phase in both fertile and non-fertile cycles, but the absolute levels differ significantly. 2

Timing Considerations

  • During normal luteal phases in non-pregnant women, E1G rises again during the mid-luteal phase (7-10 days post-ovulation), reaching levels 2-3 times higher than early follicular baseline. 5

  • In pregnancy, this elevation persists and increases further rather than declining in the late luteal phase. 2

Practical Application

  • Low E1G levels (<30 ng/mg Cr, below the 10th percentile) during the early luteal phase are associated with increased odds of early pregnancy loss (OR = 4.8). 1

  • The sustained elevation of both E1G and PDG beyond the expected late luteal decline is the key distinguishing feature of early pregnancy. 1, 2

References

2
Research

The pattern of luteal phase plasma progesterone and estradiol in fertile cycles.

American journal of obstetrics and gynecology, 1982

5
Guideline

Menstrual Cycle Physiology and Effects

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

In a patient on progesterone supplementation, with baseline estrone‑3‑glucuronide 6.2 ng/mL on cycle day 5 and urinary estrone‑3‑glucuronide ~122 ng/mL on cycle day 23–24 (≈10 days after the LH surge), does this estrogen level indicate early pregnancy and what is the probability of being pregnant?
When should progesterone levels be checked in a non-pregnant woman?
In a reproductive‑age woman receiving luteal‑phase progesterone supplementation (≈20 ng/mL) with an estradiol‑1‑glucuronide level of about 122 pg/mL on cycle day 24 (≈9–10 days post‑ovulation), can this E1g measurement be used to detect early pregnancy?
Is it possible that estrone-1-glucuronide (E1G) levels will drop significantly tomorrow in a pregnant patient with sustained progesterone (PdG) levels, 11-13 days past the initial luteinizing hormone (LH) surge, while on progesterone supplementation?
I am a woman of reproductive age using a urinary fertility monitor; based on my estrone‑3‑glucuronide (E1G), luteinising hormone (LH) and pregnanediol‑glucuronide (PDG) trends showing an LH surge peaking at 45 IU on cycle day 13 and still elevated on day 14, did I ovulate, and if so on which day? When should I begin progesterone supplementation for possible luteal phase insufficiency, and until when is the oocyte viable? Will intercourse on the evening of cycle day 15 still be within the fertile window?
What ECG findings are indicative of patent ductus arteriosus (PDA) in infants and children?
What are the contraindications for anticoagulation therapy as deep vein thrombosis (DVT) prophylaxis in patients with a history of bleeding disorders or impaired renal function?
What is the target Thyroid-Stimulating Hormone (TSH) level range for high-risk patients, including those with a history of thyroid cancer or pregnant women?
What are the recommended antihypertensives (blood pressure medications) for a patient with severe asymptomatic hypertension, nephrotic syndrome, and chronic kidney disease (CKD)?
Can aripiprazole (atypical antipsychotic) increase anxiety symptoms in patients, particularly those with a history of anxiety disorders?
Is domperidone (antiemetic) safe to use in a pregnant adult female with severe nausea and vomiting during the first trimester?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question